Stéphane Viau

TTI-621 (SIRPαFc): A CD47-Blocking Innate Immune Checkpoint Inhibitor with Broad Antitumor Activity and Minimal Erythrocyte Binding

Penka S. Petrova, Natasja Nielsen Viller, Mark Wong et al. · Clinical Cancer Research · 2016 · 269 citations

Cloning, sequencing, and expression in Escherichia coli of the D-hydantoinase gene from Pseudomonas putida and distribution of homologous genes in other microorganisms

Gisèle LaPointe, Stéphane Viau, Danielle Leblanc et al. · Applied and Environmental Microbiology · 1994 · 59 citations · Full text

Biosynthesis, Prokaryotic System, Biochemistry +12

Overexpression of vsr in Escherichia coli is mutagenic

Kathy M.J Doiron, Stéphane Viau, Maria Koutroumanis et al. · Journal of Bacteriology · 1996 · 38 citations · Full text

Genome Instability, Virulence Factor, Genetics +10

Adenovirus-mediated ribonucleotide reductase R1 gene therapy of human colon adenocarcinoma.

Ming‐Yu Cao, Yoon Seong Lee, Ningping Feng et al. · PubMed · 2003 · 36 citations

Tumor Biology, Ribonucleotide Reductase, Human Colon Adenocarcinoma +15

A novel small molecule with potent anticancer activity inhibits cell growth by modulating intracellular labile zinc homeostasis

Mario Huesca, Lisa Lock, Aye Aye Khine et al. · Molecular Cancer Therapeutics · 2009 · 31 citations